Literature DB >> 4859058

[Plasma levels, elimination and cumulation of proscillaridin in renal failure (author's transl)].

G G Belz, W J Brech.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4859058     DOI： 10.1007/BF01468800

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  25 in total

1.  STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.

Authors:  J E DOHERTY; W H PERKINS; M C WILSON
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  [ON THE PHARMACOLOGY OF A PURE GLYCOSIDE RECENTLY INTRODUCED INTO THERAPY].

Authors:  H G KURBJUWEIT
Journal:  Arzneimittelforschung       Date:  1964-06

3.  [CLINICAL EXPERIENCES WITH TALUSIN].

Authors:  W GEBHARDT; H REINDELL; J HEINING; C BUECHNER; D DANNER; F MOSER; F WOEHLER; G HOFFMANN; G WINCKELMANN
Journal:  Med Klin       Date:  1965-05-28

4.  Characterization and specificity of proscillaridin antibodies.

Authors:  G G Belz; W J Brech; U R Kleeberg; G Rudofsky; G Belz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Clinical studies on proscillaridin a new squill glycoside.

Authors:  L Gould; S Fisch; A Cherbakoff; A C DeGraff
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Mar-Apr

6.  [Comulative behavior of various cardiac glycosides in anuria].

Authors:  P Kramer; J Horenkamp; B Willms; F Scheler
Journal:  Dtsch Med Wochenschr       Date:  1970-02-27       Impact factor: 0.628

7.  [Determination of the plasma protein binding of cardiac glycosides by measuring the Na plus-K+ transport in erythrocytes].

Authors:  W Kobinger; B Wenzel
Journal:  Wien Klin Wochenschr       Date:  1970-03-13       Impact factor: 1.704

8.  [Therapeutic experiences with a new cardiac glycoside: proscillaridin A].

Authors:  G Meier; G Wagner
Journal:  Med Welt       Date:  1965-08-28

9.  Digitoxin kinetics in patients with impaired renal function.

Authors:  K Rasmussen; J Jervell; L Storstein; K Gjerdrum
Journal:  Clin Pharmacol Ther       Date:  1972 Jan-Feb       Impact factor: 6.875

10.  [Clinical studies on the cardiotonic effects of proscillaridin A].

Authors:  L Benda; D Doneff; A Lujf; K Moser
Journal:  Wien Klin Wochenschr       Date:  1966-02-11       Impact factor: 1.704
View more
  7 in total

1.  [Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)].

Authors:  M Stauch; N Grewe; G G Belz
Journal:  Klin Wochenschr       Date:  1977-07-15

2.  [Plasma concentrations and elimination of methyl proscillaridin in renal failure (author's transl)].

Authors:  G G Belz; H Nübling; P Schmidt-Wiederkehr; H E Franz
Journal:  Klin Wochenschr       Date:  1974-11-15

Review 3.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

4.  Metabolism and excretion of methylproscillaridin by man.

Authors:  N Rietbrock; R Staud
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

5.  Proscillaridin activity in portal and peripheral venous blood after oral administration to man.

Authors:  K E Andersson; B Bergdahl; H Dencker; G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 6.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

7.  Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.

Authors:  G G Belz; H Schreiter; G K Wolf
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.